Sort   by:  
 Page size 
UnknownLiquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC.
Not available
S-EPMC9600124 | biostudies-literature
UnknownMetagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African men.
Not available
S-EPMC6790596 | biostudies-literature
UnknownRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Not available
S-EPMC4086638 | biostudies-literature
Transcriptomicsdella-regulation in darkness versus light-DELLAs contribute to skotomorphogenesis
rs09-09_della-dark - della-regulation in darkness versus light - Identification of DELLA-dependent downstream targets in darkness - Aim was to determine downstream target of DELLA proteins involved in skotomorphogenesis. Wt, ga1-3, ga1-3_rga_gai_rgl1_rgl2_rgl3 global seeds were sterilized, sown on M...
ORGANISM(S): Arabidopsis thaliana 
2011-06-12 | E-GEOD-22681 | biostudies-arrayexpress
UnknownProstate cancer clinicopathological presentation in South-East Africa during the 2010 decade.
Not available
S-EPMC12682384 | biostudies-literature
UnknownSpecifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.
Not available
S-EPMC5244667 | biostudies-literature
Genomicsena-DATASET-SC-16-09-2014-14:22:12:125-153 - samples
Description not provided
EGAD00001001014 | EGA
Genomicsena-DATASET-SC-16-09-2014-14:25:48:324-154 - samples
Description not provided
EGAD00001001015 | EGA
GenomicsOrigins and functional consequence of somatic mitochondrial DNA mutations
Recent sequencing studies have extensively explored the somatic alterations present in the nuclear genomes of cancers. Although mitochondria control energy metabolism and apoptosis, the origins and impact of cancer-associated mutations in mitochondrial DNA (mtDNA) are unclear. Here, we analysed soma...
EGAS00001000968 | EGA
UnknownPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088 | biostudies-literature
Sort   by:  
 Page size